期刊文献+

0.5g/次、0.1g/次左氧氟沙星治疗淋病合并非淋菌性尿道炎的有效性及安全性 被引量:2

A Study on the Effectiveness and Safety of Levofloxacin at Doses of 0.5g/time and 0.1g/time in the Treatment of Gonorrhea Complicated with Non-Gonococcal Urethritis
下载PDF
导出
摘要 目的探讨0.5g/次、0.1g/次左氧氟沙星治疗淋病合并非淋菌性尿道炎的有效性及安全性。方法选取我院2017年3月至2018年3月68例淋病合并非淋菌性尿道炎患者,根据随时数表法分为A组34例(给予0.5g/次左氧氟沙星治疗)与B组34例(给予0.1g/次左氧氟沙星治疗),对比临床治疗效果及安全性。结果 A组治疗治愈率、病原菌清除率、治疗有效率均显著高于B组(P<0.05);两组不良反应发生率比较无意义(P<0.05)。结论左氧氟沙星治疗淋病合并非淋菌性尿道炎的疗效确切,在各条件相同情况下,给予患者0.5g/次左氧氟沙星治疗具有更好的治疗效果,且用药安全性与0.1g/次左氧氟沙星治疗相同。 Objective To explore the effectiveness and safety of levofloxacin at doses of 0.5 g/time and 0.1 g/time in the treatment of gonorrhea complicated with non-gonococcal urethritis.Methods 68 cases of gonorrhea complicated with non-gonococcal urethritis who were treated in Shenzhen Second People’s Hospital from March 2017 to March 2018 were selected for study.They were divided into two groups according to random number table method:group A(n=34,treated with levofloxacin at a dose of 0.5 g/time)and group B(n=34,treated with levofloxacin at a dose of 0.1 g/time).The clinical treatment effects and safety were compared between the two groups.Results The cure rate,clearance rate of pathogenic bacteria and treatment effective rate of the patients in group A were significantly higher than those in group B(P<0.05).The difference in the incidence of adverse reactions between the two groups was not significant(P>0.05)according to the comparison.Conclusion Levofloxacin is effective in the treatment of gonorrhea with nongonococcal urethritis.Under the same conditions,levofloxacin at a dose of 0.5 g/time enjoys a better treatment effects and the same safety compared with levofloxacin at a dose of 0.1 g/time levofloxacin.
作者 黄德顺 刘恩让 吴文中 任小蓉 谢倩 HUANG De-shun;LIU En-rang;WU Wen-zhong;REN Xiao-rong;XIE Qian(Department of Dermatology and Venereology,Shenzhen Second People's Hospital,Shenzhen,Guangdong 518000)
出处 《智慧健康》 2019年第15期159-160,162,共3页 Smart Healthcare
关键词 左氧氟沙星 淋病 非淋菌性尿道炎 Levofloxacin Gonorrhea Non-gonococcal urethritis
  • 相关文献

参考文献4

二级参考文献57

  • 1谭开明,王箭.3280例非淋菌性尿道炎中支原体感染的检测[J].中华医院感染学杂志,2006,16(2):235-237. 被引量:80
  • 2薛文成,孟冬娅,万楠,褚美玲,张春玲,方秀菊.2006年泌尿生殖系统支原体感染状况及耐药性分析[J].中国实验诊断学,2007,11(3):335-337. 被引量:22
  • 3Fan W, Zhang Q. Risk factors for male patients with gonorrhoea complicated by inflammation of the paraurethral glands around the external urethral orifice[J]. Int J STD AIDS, 2012, 23(6): 400-402.
  • 4World Health Organization. Global strategy for the prevention and control of sexually transmitted infections: 2006-2015 [ M ]. Geneva: WHO, 2006.
  • 5Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2013 [ M ]. Atlanta: U.S. Department of Health and Human Services, 2014.
  • 6World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections - 2008 [M]. Geneva: WHO, 2012.
  • 7World Health Organization. Baseline report on global sexually transmitted infection surveillance 2012[ M ]. Geneva: WHO, 2013.
  • 8Kirkcaldy RI), Weinstock HS,Moore PC, et al. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea. Clin Infect Dis,2014,59 ( 8 ) : 1083 - 1091.
  • 9Trecker MA, Dillon JA. Identification of demographic and behavioral risk factors for antibiotic resistant gonorrhea infections to combat the emergence of potentially untreatable infections. Sex Transm Dis, 2014,41 (12) :730 -731.
  • 10Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommen - dations. Sweden ,2010. Euro Surveil1,2011,16(6 ) : 19792.

共引文献99

同被引文献8

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部